Skip to content

Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in Indonesia

Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms With a One Health Approach in Blitar, East Java Province, Indonesia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05652556
Acronym
QUINDO
Enrollment
480
Registered
2022-12-15
Start date
2022-12-09
Completion date
2023-03-31
Last updated
2022-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Resistance, Microbial

Keywords

Escherichia coli, Staphylococcus aureus, Fluoroquinolones

Brief summary

The goal of this observational study is to reveal quinolone resistance profiles and mechanisms in S. aureus and E. coli in the human, animal and aquaculture sector in Blitar, Indonesia. The main questions it aims to answer are: * Obtain the quinolone resistance profiles and mechanisms of S. aureus and E. coli in human health, animal health and aquaculture health sector in Blitar, Indonesia. * Obtain the association of AMR and AMU data within and between the human health, animal health and aquaculture health sector in Blitar, for quinolones.

Detailed description

Antimicrobial resistance (AMR) has become a global threat in public health. It is mainly driven by antimicrobial use (AMU), not only in the human sector, but also in the animal and aquaculture sector. In aquaculture and terrestrial animals, antibiotics have been used as growth promoters as well as for prophylaxis and treatment for infection. It has been used on a large scale as a supplement to increase animal production in over 60 years. During the last decade, there has been an increasing antimicrobial resistance in the community regarding resistance to carbapenems, 3rd generation cephalosporins and quinolones. The World Health Organization categorized carbapenems, 3rd generation cephalosporins and quinolones as Watch antibiotics and these should be used with caution because of their high effects and their high potential to cause the development of AMR in many countries. The quinolones are broad-spectrum antibiotics that are probably one of the most widely used drugs for the treatment of several community and hospital-acquired infections in the human health sector. It is also used in aquaculture and agricultural fields, for instance in chicken farms. The use of quinolones and other Watch antibiotics in many countries monitored by the World Health Organization since 2016 varies a lot and ranges from less than 20% to more than 50%. It is well documented that several pathogenic bacteria have developed resistance as a consequence of exposure to the antimicrobials. Resistant bacteria can spread to humans directly from the food chain, and indirectly from the environmental pollution of farm effluents. This study will reveal quinolone resistance profiles and mechanisms in S. aureus and E. coli in the human, animal and aquaculture sector in Blitar, Indonesia. Population The research populations are residents (farmers and non-farmers) in Kabupaten Blitar. Sample Layer farm: Samples will be taken in layer farms in the Blitar region. The type of sample will be bootswab samples as published before; 25 E. coli isolates/farm will be collected. A total of 30 farms will be included. Aquaculture sample: Aquaculture samples will be taken from catfish ponds in several regions in Kabupaten Blitar. One sample of water or mud of one pond will be taken (the pond closest to the entrance). From this sample, 5 E. coli will be isolated. Human sample: Human samples will be taken from people on layer and aquaculture farms (farmers, farmworkers and family members of farmers), and non-farmer residents of several regions in Kabupaten Blitar. Nasal (S. aureus) and rectal (E. coli) samples will be taken after informed consent. AMU data will be collected via questionnaires.

Interventions

None listed

Sponsors

Dr. Soetomo General Hospital
CollaboratorOTHER_GOV
Balai Besar Laboratorium Kesehatan (BBLK) Surabaya
CollaboratorUNKNOWN
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
CollaboratorOTHER
Directorate of Veterinary Public Health, Ministry of Agriculture, Indonesia
CollaboratorUNKNOWN
Directorate of Animal Health, Ministry of Agriculture, Indonesia
CollaboratorUNKNOWN
Ministry of Marine and Fisheries, Indonesia
CollaboratorUNKNOWN
Utrecht University
CollaboratorOTHER
Radboud University Medical Center
CollaboratorOTHER
National Institute for Public Health and the Environment (RIVM)
CollaboratorOTHER_GOV
Erasmus Medical Center
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Informed consent

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Quinolone resistance profiles and mechanisms of S. aureus and E. coli in human health, animal health and aquaculture health sector in Blitar2023As determined by Vitek, microdilution, and whole genome sequencing.

Secondary

MeasureTime frameDescription
Association of AMR and AMU data within and between the human health, animal health and aquaculture health sector in Blitar, for quinolones2023Based on questionnaires

Contacts

Primary ContactJuliëtte A. Severin, MD PhD
j.severin@erasmusmc.nl+31107033510
Backup ContactTri Pudy Asmarawati, MD
tpasmarawati@fk.unair.ac.id+62315018436

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026